Generics Global Industry Almanac 2017-2021

Generics Global Industry Almanac 2017-2021


  • Products Id :- MLIG1744-01
  • |
  • Pages: 449
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Generics Global Industry Almanac 2017-2021

Summary

Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the global generics market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

Key Highlights

For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. The market value is evaluated at ex-factory prices. Market volume is quantified here as the percentage of the total ethical pharmaceutical market volume in a country or region which is accounted for by generic drugs. It is therefore a generics penetration rate measure, not an absolute measure of market volume. Regional volumes are calculated as weighted averages of countries which make up the region in question where volume data exists. Please note that any volumes of "1" (one) or 100% are due to rounding as MarketLine does not believe that generics will ever fully represent 100% of the medicinal market in any country or region. All currency conversions were calculated at constant average annual 2016 exchange rates.

The global generics market had total revenues of USD311.1bn in 2016, representing a compound annual growth rate (CAGR) of 9.5% between 2012 and 2016.

Market consumption volume increased with a CAGR of 2.2% between 2012 and 2016, to reach a total of 82.1% of total pharma volume in 2016.

Strong growth will continue in the emerging markets but worldwide there will be a deceleration.

Scope

Save time carrying out entry-level research by identifying the size, growth, and leading players in the global generics market

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global generics market

Leading company profiles reveal details of key generics market players' global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the global generics market with five year forecasts by both value and volume

Reasons to buy

What was the size of the global generics market by value in 2016?

What will be the size of the global generics market in 2021?

What factors are affecting the strength of competition in the global generics market?

How has the market performed over the last five years?

How large is the global generics market in relation to its regional counterparts?



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

EXECUTIVE SUMMARY

Market value

Market value forecast

Market volume

Market volume forecast

Geography segmentation

Introduction

What is this report about?

Who is the target reader?

How to use this report

Definitions

Global Generics

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Generics in Asia-Pacific

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Generics in Europe

Market Overview

Market Data

Market Segmentation 60

Market outlook

Five forces analysis

Generics in France

Market Overview

Market Data 70

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Generics in Germany

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Generics in Australia

Market Overview

Market Data

Market Segmentation 100

Market outlook

Five forces analysis

Macroeconomic indicators

Generics in Brazil

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Generics in Canada

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Generics in China

Market Overview

Market Data 140

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Generics in India

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis 160

Macroeconomic indicators

Generics in Indonesia

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators 180

Generics in Italy

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Generics in Japan

Market Overview

Market Data

Market Segmentation

Market outlook 200

Five forces analysis 20

Macroeconomic indicators 20

Generics in Mexico

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Generics in The Netherlands

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis 2

Macroeconomic indicators

Generics in North America

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Generics in Russia

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Generics in Scandinavia

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Generics in Singapore

Market Overview

Market Data

Market Segmentation 280

Market outlook

Five forces analysis

Macroeconomic indicators

Generics in South Africa

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Generics in South Korea

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Generics in Spain

Market Overview

Market Data 320

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Generics in Turkey

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Generics in The United Kingdom

Market Overview

Market Data

Market Segmentation 350

Market outlook

Five forces analysis

Macroeconomic indicators

Generics in The United States

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Company Profiles

Leading Companies

Appendix

Methodology

About MarketLine

List of Figures

Figure 1: Global generics market value: USD billion, 2012-16

Figure 2: Global generics market volume: % of total pharma volume, 2012-16

Figure 3: Global generics market geography segmentation: % share, by value, 2016

Figure 4: Global generics market value forecast: USD billion, 2016-21

Figure 5: Global generics market volume forecast: % of total pharma volume, 2016-21

Figure 6: Forces driving competition in the global generics market, 2016

Figure 7: Drivers of buyer power in the global generics market, 2016

Figure 8: Drivers of supplier power in the global generics market, 2016

Figure 9: Factors influencing the likelihood of new entrants in the global generics market, 2016

Figure 10: Factors influencing the threat of substitutes in the global generics market, 2016

Figure 11: Drivers of degree of rivalry in the global generics market, 2016

Figure 12: Asia-Pacific generics market value: USD billion, 2012-16

Figure 13: Asia-Pacific generics market volume: % of total pharma volume, 2012-16

Figure 14: Asia-Pacific generics market geography segmentation: % share, by value, 2016

Figure 15: Asia-Pacific generics market value forecast: USD billion, 2016-21

Figure 16: Asia-Pacific generics market volume forecast: % of total pharma volume, 2016-21

Figure 17: Forces driving competition in the generics market in Asia-Pacific, 2016

Figure 18: Drivers of buyer power in the generics market in Asia-Pacific, 2016

Figure 19: Drivers of supplier power in the generics market in Asia-Pacific, 2016

Figure 20: Factors influencing the likelihood of new entrants in the generics market in Asia-Pacific, 2016

Figure 21: Factors influencing the threat of substitutes in the generics market in Asia-Pacific, 2016

Figure 22: Drivers of degree of rivalry in the generics market in Asia-Pacific, 2016

Figure 23: Europe generics market value: USD billion, 2012-16

Figure 24: Europe generics market volume: % of total pharma volume, 2012-16

Figure 25: Europe generics market geography segmentation: % share, by value, 2016

Figure 26: Europe generics market value forecast: USD billion, 2016-21

Figure 27: Europe generics market volume forecast: % of total pharma volume, 2016-21

Figure 28: Forces driving competition in the generics market in Europe, 2016

Figure 29: Drivers of buyer power in the generics market in Europe, 2016

Figure 30: Drivers of supplier power in the generics market in Europe, 2016

Figure 31: Factors influencing the likelihood of new entrants in the generics market in Europe, 2016

Figure 32: Factors influencing the threat of substitutes in the generics market in Europe, 2016

Figure 33: Drivers of degree of rivalry in the generics market in Europe, 2016

Figure 34: France generics market value: USD million, 2012-16

Figure 35: France generics market volume: % of total pharma volume, 2012-16

Figure 36: France generics market geography segmentation: % share, by value, 2016

Figure 37: France generics market value forecast: USD million, 2016-21

Figure 38: France generics market volume forecast: % of total pharma volume, 2016-21

Figure 39: Forces driving competition in the generics market in France, 2016

Figure 40: Drivers of buyer power in the generics market in France, 2016

Figure 41: Drivers of supplier power in the generics market in France, 2016

Figure 42: Factors influencing the likelihood of new entrants in the generics market in France, 2016

Figure 43: Factors influencing the threat of substitutes in the generics market in France, 2016

Figure 44: Drivers of degree of rivalry in the generics market in France, 2016

Figure 45: Germany generics market value: USD million, 2012-16

Figure 46: Germany generics market volume: % of total pharma volume, 2012-16

Figure 47: Germany generics market geography segmentation: % share, by value, 2016

Figure 48: Germany generics market value forecast: USD million, 2016-21

Figure 49: Germany generics market volume forecast: % of total pharma volume, 2016-21

Figure 50: Forces driving competition in the generics market in Germany, 2016

Figure 51: Drivers of buyer power in the generics market in Germany, 2016

Figure 52: Drivers of supplier power in the generics market in Germany, 2016

Figure 53: Factors influencing the likelihood of new entrants in the generics market in Germany, 2016

Figure 54: Factors influencing the threat of substitutes in the generics market in Germany, 2016

Figure 55: Drivers of degree of rivalry in the generics market in Germany, 2016

Figure 56: Australia generics market value: USD million, 2012-16

Figure 57: Australia generics market volume: % of total pharma volume, 2012-16

Figure 58: Australia generics market geography segmentation: % share, by value, 2016

Figure 59: Australia generics market value forecast: USD million, 2016-21

Figure 60: Australia generics market volume forecast: % of total pharma volume, 2016-21

Figure 61: Forces driving competition in the generics market in Australia, 2016

Figure 62: Drivers of buyer power in the generics market in Australia, 2016

Figure 63: Drivers of supplier power in the generics market in Australia, 2016

Figure 64: Factors influencing the likelihood of new entrants in the generics market in Australia, 2016

Figure 65: Factors influencing the threat of substitutes in the generics market in Australia, 2016

Figure 66: Drivers of degree of rivalry in the generics market in Australia, 2016

Figure 67: Brazil generics market value: USD million, 2012-16

Figure 68: Brazil generics market volume: % of total pharma volume, 2012-16

Figure 69: Brazil generics market geography segmentation: % share, by value, 2016

Figure 70: Brazil generics market value forecast: USD million, 2016-21

Figure 71: Brazil generics market volume forecast: % of total pharma volume, 2016-21

Figure 72: Forces driving competition in the generics market in Brazil, 2016

Figure 73: Drivers of buyer power in the generics market in Brazil, 2016

Figure 74: Drivers of supplier power in the generics market in Brazil, 2016

Figure 75: Factors influencing the likelihood of new entrants in the generics market in Brazil, 2016

List of Tables

Table 1: Global generics market value: USD billion, 2012-16

Table 2: Global generics market volume: % of total pharma volume, 2012-16

Table 3: Global generics market geography segmentation: USD billion, 2016

Table 4: Global generics market value forecast: USD billion, 2016-21

Table 5: Global generics market volume forecast: % of total pharma volume, 2016-21

Table 6: Asia-Pacific generics market value: USD billion, 2012-16

Table 7: Asia-Pacific generics market volume: % of total pharma volume, 2012-16

Table 8: Asia-Pacific generics market geography segmentation: USD billion, 2016

Table 9: Asia-Pacific generics market value forecast: USD billion, 2016-21

Table 10: Asia-Pacific generics market volume forecast: % of total pharma volume, 2016-21

Table 11: Europe generics market value: USD billion, 2012-16

Table 12: Europe generics market volume: % of total pharma volume, 2012-16

Table 13: Europe generics market geography segmentation: USD billion, 2016

Table 14: Europe generics market value forecast: USD billion, 2016-21

Table 15: Europe generics market volume forecast: % of total pharma volume, 2016-21

Table 16: France generics market value: USD million, 2012-16

Table 17: France generics market volume: % of total pharma volume, 2012-16

Table 18: France generics market geography segmentation: USD million, 2016

Table 19: France generics market value forecast: USD million, 2016-21

Table 20: France generics market volume forecast: % of total pharma volume, 2016-21

Table 21: France size of population (million), 2012-16

Table 22: France gdp (constant 2005 prices, USD billion), 2012-16

Table 23: France gdp (current prices, USD billion), 2012-16

Table 24: France inflation, 2012-16

Table 25: France consumer price index (absolute), 2012-16

Table 26: France exchange rate, 2012-16

Table 27: Germany generics market value: USD million, 2012-16

Table 28: Germany generics market volume: % of total pharma volume, 2012-16

Table 29: Germany generics market geography segmentation: USD million, 2016

Table 30: Germany generics market value forecast: USD million, 2016-21

Table 31: Germany generics market volume forecast: % of total pharma volume, 2016-21

Table 32: Germany size of population (million), 2012-16

Table 33: Germany gdp (constant 2005 prices, USD billion), 2012-16

Table 34: Germany gdp (current prices, USD billion), 2012-16

Table 35: Germany inflation, 2012-16

Table 36: Germany consumer price index (absolute), 2012-16

Table 37: Germany exchange rate, 2012-16

Table 38: Australia generics market value: USD million, 2012-16

Table 39: Australia generics market volume: % of total pharma volume, 2012-16

Table 40: Australia generics market geography segmentation: USD million, 2016

Table 41: Australia generics market value forecast: USD million, 2016-21

Table 42: Australia generics market volume forecast: % of total pharma volume, 2016-21

Table 43: Australia size of population (million), 2012-16

Table 44: Australia gdp (constant 2005 prices, USD billion), 2012-16

Table 45: Australia gdp (current prices, USD billion), 2012-16

Table 46: Australia inflation, 2012-16

Table 47: Australia consumer price index (absolute), 2012-16

Table 48: Australia exchange rate, 2012-16

Table 49: Brazil generics market value: USD million, 2012-16

Table 50: Brazil generics market volume: % of total pharma volume, 2012-16

Table 51: Brazil generics market geography segmentation: USD million, 2016

Table 52: Brazil generics market value forecast: USD million, 2016-21

Table 53: Brazil generics market volume forecast: % of total pharma volume, 2016-21

Table 54: Brazil size of population (million), 2012-16

Table 55: Brazil gdp (constant 2005 prices, USD billion), 2012-16

Table 56: Brazil gdp (current prices, USD billion), 2012-16

Table 57: Brazil inflation, 2012-16

Table 58: Brazil consumer price index (absolute), 2012-16

Table 59: Brazil exchange rate, 2012-16

Table 60: Canada generics market value: USD million, 2012-16

Table 61: Canada generics market volume: % of total pharma volume, 2012-16

Table 62: Canada generics market geography segmentation: USD million, 2016

Table 63: Canada generics market value forecast: USD million, 2016-21

Table 64: Canada generics market volume forecast: % of total pharma volume, 2016-21

Table 65: Canada size of population (million), 2012-16

Table 66: Canada gdp (constant 2005 prices, USD billion), 2012-16

Table 67: Canada gdp (current prices, USD billion), 2012-16

Table 68: Canada inflation, 2012-16

Table 69: Canada consumer price index (absolute), 2012-16

Table 70: Canada exchange rate, 2012-16

Table 71: China generics market value: USD billion, 2012-16

Table 72: China generics market volume: % of total pharma volume, 2012-16

Table 73: China generics market geography segmentation: USD billion, 2016

Table 74: China generics market value forecast: USD billion, 2016-21

Table 75: China generics market volume forecast: % of total pharma volume, 2016-21

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

select a license
Single User License
USD 2995 INR 213424
Site License
USD 5990 INR 426847
Corporate User License
USD 8985 INR 640271

NEWSLETTER BY CATEGORY




Testimonials

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com